Given that inhibition of BET by small molecule JQ1 resulted in suppressing MYC expression and thereby induce cell death [50], a pediatric cancer trial is currently underway including assessing the BET inhibitor BMS-986158 in MB with MYC/MYCN amplification (NCT03936465). The gene discussed is MYCN; the disease is cancer.